ClinicalTrials.Veeva

Menu

Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients

C

Copenhagen University Hospital at Herlev

Status

Withdrawn

Conditions

Contrast Media
Neoplasm Metastasis
Colorectal Neoplasms
Liver
Magnetic Resonance Imaging

Study type

Observational

Funder types

Other

Identifiers

NCT00718055
KA-20060096

Details and patient eligibility

About

The purpose of this study is to determine whether MRI with manganese containing contrast agent detects more livermetastasis compared to CT scan

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • biopsy proved liver metastasis

Exclusion criteria

  • pacemaker, metal in the body, claustrophobia, pregnancy, age below 18 years, psychiatry patients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems